The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The interim result of a phase I/II study of nivolumab with or without ipilimumab in combination with multi-fraction stereotactic radiosurgery for recurrent, high-grade, radiation-relapsed meningioma.
 
Jiayi Huang
Research Funding - Cantex Pharmaceuticals; Pfizer/EMD Serono
 
Feng Gao
No Relationships to Disclose
 
Joshua Shimony
No Relationships to Disclose
 
Tanner Michael Johanns
Consulting or Advisory Role - Geneos; Novocure
 
Megan Mantica
No Relationships to Disclose
 
Timothy Robin Gershon
No Relationships to Disclose
 
Douglas Edward Ney
Consulting or Advisory Role - DNAtrix
Research Funding - Denovo Biopharma (Inst); Orbus Therapeutics
 
Tolga Tuncer
No Relationships to Disclose
 
Joe Sammy Mendez
No Relationships to Disclose
 
Howard Streicher
No Relationships to Disclose
 
Jian Li Campian
Consulting or Advisory Role - Alexion Pharmaceuticals; Arbor Pharmaceuticals; Dova Pharmaceuticals; Incyte; Inovio Pharmaceuticals
Speakers' Bureau - Abbvie (I)
Research Funding - NeoImmuneTech
Travel, Accommodations, Expenses - NantWorks